van Kempen ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, et al. Personalized extended interval dosing of natalizumab in MS: A prospective
multicenter trial. Neurology 2020;95:e745-e754.
PMID: 32690785
![]() |
![]() |
![]() |
Free Medical Abstracts
Privacy Policy
Sponsors
Share
About
© Amedeo 1997-2016